Cytokine release syndrome after CAR infusion in pediatric patients with refractory/relapsed B-ALL: is there a role for diclofenac?
Sara NapolitanoGiorgio OttavianoLaura BettiniVincenzo RussottoSonia BonanomiAttilio RovelliAndrea BiondiRoberto RonaAdriana BalduzziPublished in: Tumori (2021)
Based on a limited number of patients, diclofenac leads to better fever control, which translates into symptom relief and improvement of tachycardia, but could not prevent the progression of CRS.